Consistency of Response With Rimegepant in Acute Treatment of Migraine

Not yet recruitingOBSERVATIONAL
Enrollment

250

Participants

Timeline

Start Date

September 17, 2025

Primary Completion Date

May 29, 2026

Study Completion Date

May 29, 2026

Conditions
Migraine
Interventions
DRUG

Rimegepant for acute migraine treatment

Rimegepant for acute migraine treatment

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Pfizer

INDUSTRY

NCT06898047 - Consistency of Response With Rimegepant in Acute Treatment of Migraine | Biotech Hunter | Biotech Hunter